CSBR:NASDAQ
Champions Oncology Inc
$4.78
arrow_upward
+0.63%(+0.030) 1D
Nov 11, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.79
High
$4.81
Low
$4.64
Mkt. cap
66.53M
Avg. vol.
8.97K
Volume
9.35K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.79
High
$4.81
Low
$4.64
Mkt. cap
66.53M
Avg. vol.
8.97K
Volume
9.35K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
The Washington Post
·
28 minutes ago
How major US stock indexes fared Wednesday 11/11/2026
Yahoo Finance
·
1 hour ago
History Says 1 Month Has Been the S&P 500's Most Reliable Since 1950. It's Only Weeks Away.
24/7 Wall St.
·
48 minutes ago
S&P 500 Closes Up 1.3% as Tech Pulls the Market Higher
Traders Union
·
2 hours ago
S&P 500 dropped 19.35% and JOJO.Index was up 4.78% in the Q4 2018 backtest, Michael A. Gayed notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com